Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label Gemcitabine. Show all posts
Showing posts with label Gemcitabine. Show all posts
Thursday, May 24, 2012

Clinical Care Options - OCEANS: PFS Improvement of 4 Months With the Addition of Bevacizumab to Carboplatin/Gemcitabine in Patients With Platinum-Sensitive Recurrent Ovarian Cancer ASCO 2011

›
 Blogger's Note : requires registration (free) to view Clinical Care Options - Oncology CME - OCEANS: PFS Improvement of 4 Months With...
Tuesday, May 01, 2012

Medscape: Bevacizumab Benefits Patients With Recurrent Ovarian Cancer (bevacizumab plus carboplatin and gemcitabine followed by bevacizumab)

›
Bevacizumab Benefits Patients With Recurrent Ovarian Cancer
Wednesday, April 25, 2012

Add-on bevacizumab slows progression of recurrent ovarian cancer - - ModernMedicine

›
Add-on bevacizumab slows progression of recurrent ovarian cancer - - ModernMedicine (from Reuters) ".... Dr. Aghajanian and colleagu...
Thursday, April 05, 2012

abstract: Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer

›
Abstract To evaluate the activity of gemcitabine and docetaxel in patients with recurrent ovarian cancer . Methods:  Patients with p...
Wednesday, July 13, 2011

abstract: Feasibility of intravenous gemcitabine and an intraperitoneal platinum agent in the treatment of ovarian cancer

›
Thursday, October 07, 2010

prior abstract - new commentary: EvidenceUpdates - Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment

›
Commentary: Oncology - Gynecology - "This negative study extends the evidence base indicating that triplet chemotherapy increases to...
Monday, September 20, 2010

Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium

›
Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; †Juravinski Cancer Centre, McMaster University,Hamilton, Onta...
Monday, September 13, 2010

Summary-Overcoming platinum resistance in ovarian carcinoma

›
Areas covered in this review: A systematic literature review of clinical studies published between January 2005 and March 2010 was conduc...
Wednesday, February 24, 2010

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer - abstract

›
Conclusion: Pertuzumab may add activity to gemcitabine for the treatment of platinum-resistant ovarian cancer. Low HER3 mRNA expression m...
Tuesday, February 02, 2010

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

›
Note: The response rates in this study either alone or in combination were low. The side effects appear to be understated (abstract).